David A. Siegel Ideaya Biosciences, Inc. Transaction History

Two Sigma Advisers, LP

$42.8 Billion
Q1 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 413,600 shares of IDYA stock, worth $8.96 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

413,600

Previous 460,600 10.2%

Holding current value

$8.96 Million

Previous $11.8 Million 42.77%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$16.38 - $26.0 $769,860 - $1.22 Million	-47,000 Reduced 10.2%	413,600 $6.77 Million
Q4 2024 Feb 14, 2025	SELL	$24.79 - $31.98 $185,925 - $239,850	-7,500 Reduced 1.6%	460,600 $11.8 Million
Q3 2024 Nov 14, 2024	BUY	$30.37 - $43.05 $233,849 - $331,485	7,700 Added 1.67%	468,100 $14.8 Million
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $1.06 Million - $1.34 Million	-30,900 Reduced 6.29%	460,400 $16.2 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $15.2 Million - $20.9 Million	443,300 Added 923.54%	491,300 $21.6 Million
Q4 2023 Feb 14, 2024	SELL	$24.59 - $35.83 $2.18 Million - $3.17 Million	-88,600 Reduced 64.86%	48,000 $1.71 Million
Q3 2023 Nov 14, 2023	SELL	$21.07 - $29.77 $1.84 Million - $2.6 Million	-87,200 Reduced 38.96%	136,600 $3.69 Million
Q2 2023 Aug 14, 2023	SELL	$13.33 - $25.53 $777,139 - $1.49 Million	-58,300 Reduced 20.67%	223,800 $5.26 Million
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $2.11 Million - $2.93 Million	156,500 Added 124.6%	282,100 $3.87 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $1.27 Million - $1.59 Million	87,700 Added 231.4%	125,600 $2.28 Million
Q3 2022 Nov 14, 2022	SELL	$9.24 - $15.79 $57,288 - $97,898	-6,200 Reduced 14.06%	37,900 $565,000
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $290,628 - $487,188	-35,100 Reduced 44.32%	44,100 $609,000
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $755,768 - $1.62 Million	67,600 Added 582.76%	79,200 $886,000
Q4 2021 Feb 14, 2022	SELL	$20.95 - $26.88 $861,045 - $1.1 Million	-41,100 Reduced 77.99%	11,600 $274,000
Q3 2021 Nov 15, 2021	SELL	$17.26 - $27.08 $1.43 Million - $2.24 Million	-82,800 Reduced 61.11%	52,700 $1.34 Million
Q2 2021 Aug 16, 2021	SELL	$17.76 - $24.83 $1.32 Million - $1.85 Million	-74,500 Reduced 35.48%	135,500 $2.84 Million
Q1 2021 May 17, 2021	SELL	$13.48 - $23.77 $119,972 - $211,553	-8,900 Reduced 4.07%	210,000 $4.94 Million
Q4 2020 Feb 16, 2021	BUY	$12.17 - $17.52 $966,298 - $1.39 Million	79,400 Added 56.92%	218,900 $3.07 Million
Q3 2020 Nov 16, 2020	BUY	$11.22 - $14.46 $1.57 Million - $2.02 Million	139,500 New	139,500 $1.75 Million

Others Institutions Holding IDYA

# of Institutions

212

Shares Held

80.3M

Call Options Held

80.3K

Put Options Held

30.5K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.04B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account